Vera Therapeutics (VERA) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Vera Therapeutics

· VERA

Dashboard

Financials

Ratios

Valuation

Statistics

2.333 B

-0.26%

Vera Therapeutics (VERA) Company Statistics | The Fly

General

Market Cap: $2.33B
Enterprise Value: $2.34B
Shares Outstanding: 71,780,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -75.40%
ROE: -84.13%
ROIC: -85.78%
Current Ratio: 10.92
Debt-to-Equity: 0.18
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.09
P/S: —
P/FCF: —
P/B: 5.68
EV/EBITDA: -6.01

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $416.89M
Operating Income: -$415.76M
Net Profit: -$401.9M

Balance Sheet

Cash and Equivalents: $48.88M
Working Capital: $479.17M
Total Assets: $532.98M
Net Debt: $26.35M
Total Liabilities: $125.23M
Total Equity: $407.76M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$338.65M
Cash Flow from Investing: $45.47M
Cash Flow from Financing: $292.94M
Free Cash Flow: -$339.06M
Capital Expenditures: $408K